000 | 01963 a2200505 4500 | ||
---|---|---|---|
005 | 20250518083102.0 | ||
264 | 0 | _c20200630 | |
008 | 202006s 0 0 eng d | ||
022 | _a1878-3511 | ||
024 | 7 |
_a10.1016/j.ijid.2020.01.045 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMedise, Bernie Endyarni | |
245 | 0 | 0 |
_aOne-month follow up of a randomized clinical trial-phase II study in 6 to <24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine. _h[electronic resource] |
260 |
_bInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _cApr 2020 |
||
300 |
_a102-107 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDiphtheria Toxoid |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIndonesia |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPain _xetiology |
650 | 0 | 4 | _aPolysaccharides, Bacterial |
650 | 0 | 4 | _aSeroconversion |
650 | 0 | 4 |
_aTyphoid-Paratyphoid Vaccines _xadverse effects |
650 | 0 | 4 | _aVaccination |
650 | 0 | 4 |
_aVaccines, Conjugate _xadverse effects |
700 | 1 | _aSoedjatmiko, Soedjatmiko | |
700 | 1 | _aGunardi, Hartono | |
700 | 1 | _aSekartini, Rini | |
700 | 1 | _aSatari, Hindra Irawan | |
700 | 1 | _aHadinegoro, Sri Rezeki | |
700 | 1 | _aWirahmadi, Angga | |
700 | 1 | _aPuspita, Mita | |
700 | 1 | _aSari, Rini Mulia | |
700 | 1 | _aYang, Jae Seung | |
700 | 1 | _aSil, Arijit | |
700 | 1 | _aSahastrabuddhe, Sushant | |
700 | 1 | _aBachtiar, Novilia Sjafri | |
773 | 0 |
_tInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _gvol. 93 _gp. 102-107 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijid.2020.01.045 _zAvailable from publisher's website |
999 |
_c30582668 _d30582668 |